New Results
Thyroid and androgen receptor signaling are antagonized by CRYM in prostate cancer
Osman Aksoy, Jan Pencik, Markus Hartenbach, Ali A. Moazzami, Michaela Schlederer, Theresa Balber, Bismoy Mazumder, Jonathan B Whitchurch, Christopher J. Roberts, Martin Susani, Markus Mitterhauser, Rodrig Marculescu, Gero Kramer, View ORCID ProfileSuzanne D. Turner, Sabrina Hartenbach, Simone Tangermann, Gerda Egger, Heidi A. Neubauer, Richard Moriggl, Zoran Culig, Gregor Hoermann, Marcus Hacker, View ORCID ProfileDavid M. Heery, Olaf Merkel, Lukas Kenner
doi: https://doi.org/10.1101/2019.12.19.881151
Osman Aksoy
1Department of Pathology, Medical University Vienna, Vienna, Austria
Jan Pencik
1Department of Pathology, Medical University Vienna, Vienna, Austria
2Center for Biomarker Research in Medicine (CBmed), Graz, Austria
Markus Hartenbach
3Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University Vienna
4Histo Consulting Inc., Ulm, Germany
Ali A. Moazzami
5Department of Molecular Sciences, Uppsala BioCenter, Swedish University of Agricultural Sciences, Uppsala, Sweden
Michaela Schlederer
1Department of Pathology, Medical University Vienna, Vienna, Austria
Theresa Balber
2Center for Biomarker Research in Medicine (CBmed), Graz, Austria
6Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
7Department for Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Austria
Bismoy Mazumder
8School of Pharmacy, University of Nottingham, Nottingham, United Kingdom
Jonathan B Whitchurch
8School of Pharmacy, University of Nottingham, Nottingham, United Kingdom
Christopher J. Roberts
8School of Pharmacy, University of Nottingham, Nottingham, United Kingdom
Martin Susani
1Department of Pathology, Medical University Vienna, Vienna, Austria
Markus Mitterhauser
2Center for Biomarker Research in Medicine (CBmed), Graz, Austria
6Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
7Department for Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Austria
Rodrig Marculescu
9Department of Urology, Medical University Vienna, Vienna, Austria
Gero Kramer
9Department of Urology, Medical University Vienna, Vienna, Austria
Suzanne D. Turner
10Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
Sabrina Hartenbach
4Histo Consulting Inc., Ulm, Germany
Simone Tangermann
11Unit for Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria
Gerda Egger
1Department of Pathology, Medical University Vienna, Vienna, Austria
6Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
Heidi A. Neubauer
12Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria
Richard Moriggl
12Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria
13Ludwig Boltzmann Platform for Comparative Laboratory Animal Pathology, Vienna, Austria
Zoran Culig
14Department of Urology, Innsbruck Medical University, Innsbruck, Austria
Gregor Hoermann
15Department of Laboratory Medicine, Medical University Vienna, Vienna, Austria
16Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital Innsbruck, Innsbruck, Austria
Marcus Hacker
2Center for Biomarker Research in Medicine (CBmed), Graz, Austria
3Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University Vienna
David M. Heery
8School of Pharmacy, University of Nottingham, Nottingham, United Kingdom
Olaf Merkel
1Department of Pathology, Medical University Vienna, Vienna, Austria
Lukas Kenner
1Department of Pathology, Medical University Vienna, Vienna, Austria
2Center for Biomarker Research in Medicine (CBmed), Graz, Austria
11Unit for Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria
13Ludwig Boltzmann Platform for Comparative Laboratory Animal Pathology, Vienna, Austria
17Christian Doppler Laboratory for Applied Metabolomics (CDL-AM), Medical University of Vienna
Article usage
Posted December 19, 2019.
Thyroid and androgen receptor signaling are antagonized by CRYM in prostate cancer
Osman Aksoy, Jan Pencik, Markus Hartenbach, Ali A. Moazzami, Michaela Schlederer, Theresa Balber, Bismoy Mazumder, Jonathan B Whitchurch, Christopher J. Roberts, Martin Susani, Markus Mitterhauser, Rodrig Marculescu, Gero Kramer, Suzanne D. Turner, Sabrina Hartenbach, Simone Tangermann, Gerda Egger, Heidi A. Neubauer, Richard Moriggl, Zoran Culig, Gregor Hoermann, Marcus Hacker, David M. Heery, Olaf Merkel, Lukas Kenner
bioRxiv 2019.12.19.881151; doi: https://doi.org/10.1101/2019.12.19.881151
Thyroid and androgen receptor signaling are antagonized by CRYM in prostate cancer
Osman Aksoy, Jan Pencik, Markus Hartenbach, Ali A. Moazzami, Michaela Schlederer, Theresa Balber, Bismoy Mazumder, Jonathan B Whitchurch, Christopher J. Roberts, Martin Susani, Markus Mitterhauser, Rodrig Marculescu, Gero Kramer, Suzanne D. Turner, Sabrina Hartenbach, Simone Tangermann, Gerda Egger, Heidi A. Neubauer, Richard Moriggl, Zoran Culig, Gregor Hoermann, Marcus Hacker, David M. Heery, Olaf Merkel, Lukas Kenner
bioRxiv 2019.12.19.881151; doi: https://doi.org/10.1101/2019.12.19.881151
Subject Area
Subject Areas
- Biochemistry (11700)
- Bioengineering (8715)
- Bioinformatics (29120)
- Biophysics (14927)
- Cancer Biology (12047)
- Cell Biology (17347)
- Clinical Trials (138)
- Developmental Biology (9405)
- Ecology (14140)
- Epidemiology (2067)
- Evolutionary Biology (18262)
- Genetics (12216)
- Genomics (16761)
- Immunology (11840)
- Microbiology (27999)
- Molecular Biology (11549)
- Neuroscience (60784)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3228)
- Physiology (4937)
- Plant Biology (10382)
- Synthetic Biology (2876)
- Systems Biology (7332)
- Zoology (1642)